Suppr超能文献

成年糖尿病患者的菌血症

Bacteremia in adult diabetic patients.

作者信息

Leibovici L, Samra Z, Konisberger H, Kalter-Leibovici O, Pitlik S D, Drucker M

机构信息

Department of Internal Medicine B, Beilinson Medical Center, Petah Tiqva, Israel.

出版信息

Diabetes Care. 1991 Feb;14(2):89-94. doi: 10.2337/diacare.14.2.89.

Abstract

OBJECTIVE

To compare the microbiology, sources, complications, and outcome of bacteremia in diabetic and nondiabetic patients.

RESEARCH DESIGN AND METHODS

A prospective study was conducted of all episodes of bacteremia in hospitalized diabetic and nondiabetic patients. The study consisted of patients greater than or equal to 18 yr of age with bacteremia detected within a 19-mo interval.

RESULTS

We compared 124 episodes of bacteremia in 119 diabetic patients to 508 episodes in 480 nondiabetic patients. Diabetic patients were older than nondiabetic patients (median age 74 vs. 68 yr, P = 0.0001). In patients with an indwelling urinary catheter and bacteremic urinary tract infection, the percentage of Klebsiella in diabetic patients was 60% (6 of 10) and in nondiabetic patients was 17% (4 of 23, P = 0.04). In patients without an obvious source of bacteremia, the percentage of staphylococcal isolates in diabetic patients was 29% (10 of 35) and in nondiabetic patients was 14% (24 of 176, P = 0.04). Staphylococci were a common cause of bacteremic infections of the extremities in diabetic patients (12 of 19, 63%) and nondiabetic patients (20 of 50, 40%). Septic shock was the only complication that was more common in diabetic patients. The mortality in diabetic and nondiabetic patients was 28 and 29%, respectively.

CONCLUSIONS

Our results represent elderly patients with non-insulin-dependent diabetes mellitus. In this group, empirical treatment for suspected bacteremic urinary tract infection in patients with a urinary catheter should include coverage for Klebsiella. Empiric treatment for suspected bacteremia of unknown origin or caused by infection of the extremities should include an antistaphylococcal drug. The prognosis of bacteremia in diabetic and nondiabetic patients was similar.

摘要

目的

比较糖尿病患者与非糖尿病患者菌血症的微生物学特征、感染源、并发症及转归。

研究设计与方法

对住院糖尿病患者和非糖尿病患者的所有菌血症发作进行前瞻性研究。该研究纳入年龄大于或等于18岁、在19个月期间内检测到菌血症的患者。

结果

我们将119例糖尿病患者的124次菌血症发作与480例非糖尿病患者的508次菌血症发作进行了比较。糖尿病患者比非糖尿病患者年龄大(中位年龄74岁对68岁,P = 0.0001)。在留置导尿管且发生菌血症性尿路感染的患者中,糖尿病患者克雷伯菌属的比例为60%(10例中的6例),非糖尿病患者为17%(23例中的4例,P = 0.04)。在无明显菌血症来源的患者中,糖尿病患者葡萄球菌分离株的比例为29%(35例中的10例),非糖尿病患者为14%(176例中的24例,P = 0.04)。葡萄球菌是糖尿病患者(19例中的12例,63%)和非糖尿病患者(50例中的20例,40%)四肢菌血症性感染的常见原因。感染性休克是唯一在糖尿病患者中更常见的并发症。糖尿病患者和非糖尿病患者的死亡率分别为28%和29%。

结论

我们的研究结果代表了非胰岛素依赖型糖尿病老年患者。在该组中,对留置导尿管的疑似菌血症性尿路感染患者进行经验性治疗应覆盖克雷伯菌属。对疑似不明来源菌血症或由四肢感染引起的菌血症进行经验性治疗应包括抗葡萄球菌药物。糖尿病患者和非糖尿病患者菌血症的预后相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验